BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 26015807)

  • 21. Involvement of the concentrative nucleoside transporter 3 and equilibrative nucleoside transporter 2 in the resistance of T-lymphoblastic cell lines to thiopurines.
    Fotoohi AK; Lindqvist M; Peterson C; Albertioni F
    Biochem Biophys Res Commun; 2006 Apr; 343(1):208-15. PubMed ID: 16530731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thiopurine methyltransferase polymorphisms and mercaptopurine tolerance in Turkish children with acute lymphoblastic leukemia.
    Albayrak M; Konyssova U; Kaya Z; Gursel T; Guntekin S; Percin EF; Kocak U
    Cancer Chemother Pharmacol; 2011 Nov; 68(5):1155-9. PubMed ID: 21400026
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Constitutive activation of the ATM/BRCA1 pathway prevents DNA damage-induced apoptosis in 5-azacytidine-resistant cell lines.
    Imanishi S; Umezu T; Ohtsuki K; Kobayashi C; Ohyashiki K; Ohyashiki JH
    Biochem Pharmacol; 2014 Jun; 89(3):361-9. PubMed ID: 24680865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease.
    Gearry RB; Barclay ML
    J Gastroenterol Hepatol; 2005 Aug; 20(8):1149-57. PubMed ID: 16048561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A serine 37 mutation associated with two missense mutations at highly conserved regions of p53 affect pro-apoptotic genes expression in a T-lymphoblastoid drug resistant cell line.
    Cinti C; Claudio PP; Luca AD; Cuccurese M; Howard CM; D'Esposito M; Paggi MG; Sala DL; Azzoni L; Halazonetis TD; Giordano A; Maraldi NM
    Oncogene; 2000 Oct; 19(44):5098-105. PubMed ID: 11042698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thiopurine methyltransferase: should it be measured before commencing thiopurine drug therapy?
    Sanderson J; Ansari A; Marinaki T; Duley J
    Ann Clin Biochem; 2004 Jul; 41(Pt 4):294-302. PubMed ID: 15298741
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thiopurine S-methyltransferase pharmacogenetics in childhood acute lymphoblastic leukemia.
    Yang JJ; Bhojwani D
    Methods Mol Biol; 2013; 999():273-84. PubMed ID: 23666706
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thiopurine methyl-transferase activity and azathioprine metabolite concentrations do not predict clinical outcome in thiopurine-treated inflammatory bowel disease patients.
    González-Lama Y; Bermejo F; López-Sanromán A; García-Sánchez V; Esteve M; Cabriada JL; McNicholl AG; Pajares R; Casellas F; Merino O; Carpio D; Vera MI; Muñoz C; Calvo M; Benito LM; Bujanda L; García-Fernández FJ; Ricart E; Ginard D; Velasco M; Carneros JA; Manceñido N; Calvo M; Algaba A; Froilan C; Cara C; Maté J; Abreu L; Gisbert JP;
    Aliment Pharmacol Ther; 2011 Sep; 34(5):544-54. PubMed ID: 21722149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic polymorphism of inosine-triphosphate-pyrophosphatase influences mercaptopurine metabolism and toxicity during treatment of acute lymphoblastic leukemia individualized for thiopurine-S-methyl-transferase status.
    Stocco G; Crews KR; Evans WE
    Expert Opin Drug Saf; 2010 Jan; 9(1):23-37. PubMed ID: 20021291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytotoxic effect of 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside (AICAR) on childhood acute lymphoblastic leukemia (ALL) cells: implication for targeted therapy.
    Sengupta TK; Leclerc GM; Hsieh-Kinser TT; Leclerc GJ; Singh I; Barredo JC
    Mol Cancer; 2007 Jul; 6():46. PubMed ID: 17623090
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thiopurine treatment in patients with Crohn's disease leads to a selective reduction of an effector cytotoxic gene expression signature revealed by whole-genome expression profiling.
    Bouma G; Baggen JM; van Bodegraven AA; Mulder CJ; Kraal G; Zwiers A; Horrevoets AJ; van der Pouw Kraan CT
    Mol Immunol; 2013 Jul; 54(3-4):472-81. PubMed ID: 23454163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA damage-associated dysregulation of the cell cycle and apoptosis control in cells with germ-line p53 mutation.
    Goi K; Takagi M; Iwata S; Delia D; Asada M; Donghi R; Tsunematsu Y; Nakazawa S; Yamamoto H; Yokota J; Tamura K; Saeki Y; Utsunomiya J; Takahashi T; Ueda R; Ishioka C; Eguchi M; Kamata N; Mizutani S
    Cancer Res; 1997 May; 57(10):1895-902. PubMed ID: 9157982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interference free and simplyfied liquid chromatography-based determination of thiopurine S-methyltransferase activity in erythrocytes.
    Khalil MN; Erb N; Khalil PN; Escherich G; Janka-Schaub GE
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Jul; 821(1):105-11. PubMed ID: 15897017
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thiopurine methyltransferase (TPMT) genotype and early treatment response to mercaptopurine in childhood acute lymphoblastic leukemia.
    Stanulla M; Schaeffeler E; Flohr T; Cario G; Schrauder A; Zimmermann M; Welte K; Ludwig WD; Bartram CR; Zanger UM; Eichelbaum M; Schrappe M; Schwab M
    JAMA; 2005 Mar; 293(12):1485-9. PubMed ID: 15784872
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel gene delivery system for stable transfection of thiopurine-S-methyltransferase gene in versatile cell types.
    Egle R; Milek M; Mlinaric-Rascan I; Fahr A; Kristl J
    Eur J Pharm Biopharm; 2008 May; 69(1):23-30. PubMed ID: 17988843
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cellular response to 5-fluorouracil (5-FU) in 5-FU-resistant colon cancer cell lines during treatment and recovery.
    De Angelis PM; Svendsrud DH; Kravik KL; Stokke T
    Mol Cancer; 2006 May; 5():20. PubMed ID: 16709241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The pattern of gene expression and gene dose profiles of 6-Mercaptopurine- and 6-Thioguanine-resistant human leukemia cells.
    Karim H; Hashemi J; Larsson C; Moshfegh A; Fotoohi AK; Albertioni F
    Biochem Biophys Res Commun; 2011 Jul; 411(1):156-61. PubMed ID: 21723252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of Patients With Variants in TPMT and Dose Reduction Reduces Hematologic Events During Thiopurine Treatment of Inflammatory Bowel Disease.
    Coenen MJ; de Jong DJ; van Marrewijk CJ; Derijks LJ; Vermeulen SH; Wong DR; Klungel OH; Verbeek AL; Hooymans PM; Peters WH; te Morsche RH; Newman WG; Scheffer H; Guchelaar HJ; Franke B;
    Gastroenterology; 2015 Oct; 149(4):907-17.e7. PubMed ID: 26072396
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genome-wide transcriptomic variations of human lymphoblastoid cell lines: insights from pairwise gene-expression correlations.
    Vincent M; Oved K; Morag A; Pasmanik-Chor M; Oron-Karni V; Shomron N; Gurwitz D
    Pharmacogenomics; 2012 Dec; 13(16):1893-904. PubMed ID: 23215882
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The thiopurine methyltransferase genetic polymorphism is associated with thioguanine-related veno-occlusive disease of the liver in children with acute lymphoblastic leukemia.
    Lennard L; Richards S; Cartwright CS; Mitchell C; Lilleyman JS; Vora A;
    Clin Pharmacol Ther; 2006 Oct; 80(4):375-83. PubMed ID: 17015055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.